DANIELLE MCLAREN: Open Payments
NPI 1285237164 · HOMEWOOD, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,387 in 96 payments from 21 companies in 2025. Trend: 2023 $1,394 · 2024 $2,016 · 2025 $2,387
Food & beverage: $2,287Education: $100
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 41 | $559 |
| Boston Scientific Corporation | 7 | $305 |
| ABBVIE INC. | 11 | $273 |
| Procept Biorobotics Corporation | 3 | $192 |
| Astellas Pharma US Inc | 3 | $152 |
| Olympus America Inc. | 6 | $136 |
| PROGENICS PHARMACEUTICALS, INC. | 2 | $112 |
| TOLMAR, INC. | 1 | $110 |
| UROGEN PHARMA, INC. | 3 | $94 |
| Merck Sharp & Dohme LLC | 3 | $78 |
Products named: GEMTESA, AMS 700, ORGOVYX, BOTOX, AQUABEAM ROBOTIC SYSTEM, iTIND System, PYLARIFY, JATENZO.
Industry payments across IL — which companies pay providers there.
